Skip to main content
Green Cross Corporation logo

Green Cross Corporation — Investor Relations & Filings

Ticker · 006280 ISIN · KR7006280002 KO Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 006280

About Green Cross Corporation

https://www.gccorp.com/eng/index

Green Cross Corporation, also known as GC Biopharma, is a biopharmaceutical company focused on developing and manufacturing life-sustaining protein therapeutics and other biological medications. Established in 1967, the company has a long history in plasma-derived products and vaccines. Its business portfolio encompasses several key areas: Biopharma, which includes blood products, vaccines, cell therapies, and treatments for rare diseases; Diagnostics, providing services from clinical trials to specialized testing; Digital Healthcare, offering services through a digital platform; and Consumer Health, which supports daily wellness with functional foods and injections. The company is committed to developing innovative new drugs and expanding its role in various healthcare fields.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Korean for “Quarterly Report”) for the period January 1 – March 31, 2026 (58th fiscal period), and runs over 330,000 characters. It contains actual financial data tables (revenue by segment, production capacity, risk management disclosures, foreign exchange exposure, etc.) rather than merely announcing or certifying a report. This matches the definition of an Interim/Quarterly Report (Code: IR). Q1 2026
2026-05-15 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 95% confidence The document is a ‘최대주주등 소유주식변동신고서’ (report of changes in major shareholder’s ownership), detailing share counts and percentages before and after transactions by the major shareholder and related parties. It matches the definition of a Major Shareholding Notification (MRQ).
2026-05-11 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Regulatory Filings
2026-05-08 Korean
투자판단관련주요경영사항
Regulatory Filings
2026-05-06 Korean
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “정기주주총회결과” and provides detailed results of an Annual General Meeting: approval of financial statements, dividend resolutions, director appointments, record dates, and vote tallies (approval rates, vote counts) for each agenda item. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-03-31 Korean
타법인주식및출자증권처분결정
Regulatory Filings Classification · 80% confidence The document is a Korean disclosure titled “Decision to dispose of other corporation’s stocks and equity securities,” detailing the sale of 3,920,250 shares, disposal amount, board resolution date, and related financial summary. It is an asset disposal announcement (regulatory disclosure) rather than an earnings release, management change, M&A, or share issue. No specific category fits perfectly, so it falls under the fallback “Regulatory Filings” (RNS).
2026-03-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.